- Home
- XPEL vs ABSI Comparison
XPEL vs ABSI Comparison
Compare XPEL & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XPEL | ABSI |
|---|---|---|
| Founded | 1999 | 2011 |
| Country | United States | United States |
| Employees | N/A | 140 |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2019 | 2021 |
Fundamental Metrics
Financial Performance| Metric | XPEL | ABSI |
|---|---|---|
| Price | $45.17 | $9.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $61.67 | $14.90 |
| AVG Volume (30 Days) | 147.3K | ★ 3.8M |
| Earning Date | 11-04-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 12.12 | 10.64 |
| EPS | ★ 1.03 | N/A |
| Revenue | ★ $476,200,000.00 | $4,534,000.00 |
| Revenue This Year | $11.71 | $39.03 |
| Revenue Next Year | $10.64 | $310.91 |
| P/E Ratio | $42.28 | ★ N/A |
| Revenue Growth | ★ 13.27 | N/A |
| 52 Week Low | $31.88 | $2.24 |
| 52 Week High | $55.91 | $12.06 |
Technical Indicators
Market Signals| Indicator | XPEL | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 40.70 | 43.42 |
| Support Level | $42.57 | $8.17 |
| Resistance Level | $46.81 | $11.73 |
| Average True Range (ATR) | 1.16 | 0.77 |
| MACD | 0.05 | -0.24 |
| Stochastic Oscillator | 10.91 | 10.88 |
Price Performance
Historical ComparisonAbout XPEL XPEL Inc.
XPEL Inc is a supplier of protective films, coatings, and related services principally to the automobile aftermarket, new car dealerships, and automobile original equipment manufacturers, or OEMs. The majority of its revenue is derived from Product, which includes Paint protection film and Window film. The company derives revenue from Service, which includes Software, Cutbank credits, and Installation labor. The majority of revenue is derived from the United States.
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process. Its lead product candidate, ABS-201, is an anti-prolactin receptor (PRLR) antibody engineered with an extended half-life to support a patient-friendly dosing interval.